Research Article
Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma
Table 2
Clinicopathological characteristics of KIRC patients included in this study.
| | Overall | High risk | Low risk | | | 530 | 220 | 310 | |
| | Age (mean (SD)) | 60.56 (12.14) | 61.08 (12.24) | 60.20 (12.07) | 0.409 | | Gender = female/male (%) | 186/344 (35.1/64.9) | 76/144 (34.5/65.5) | 110/200 (35.5/64.5) | 0.896 | | Grade (%) | | | | <0.001 | | G1 | 14 (2.6) | 3 (1.4) | 11 (3.5) | | | G2 | 227 (42.8) | 70 (31.8) | 157 (50.6) | | | G3 | 206 (38.9) | 93 (42.3) | 113 (36.5) | | | G4 | 75 (14.2) | 53 (24.1) | 22 (7.1) | | | GX | 5 (0.9) | 1 (0.5) | 4 (1.3) | | | Unknown | 3 (0.6) | 0 (0.0) | 3 (1.0) | | | Stage (%) | | | | <0.001 | | Stage I | 265 (50.0) | 76 (34.5) | 189 (61.0) | | | Stage II | 57 (10.8) | 25 (11.4) | 32 (10.3) | | | Stage III | 123 (23.2) | 61 (27.7) | 62 (20.0) | | | Stage IV | 82 (15.5) | 55 (25.0) | 27 (8.7) | | | Unknown | 3 (0.6) | 3 (1.4) | 0 (0.0) | | | T (%) | | | | <0.001 | | T1 | 21 (4.0) | 8 (3.6) | 13 (4.2) | | | T1a | 140 (26.4) | 35 (15.9) | 105 (33.9) | | | T1b | 110 (20.8) | 35 (15.9) | 75 (24.2) | | | T2 | 55 (10.4) | 22 (10.0) | 33 (10.6) | | | T2a | 10 (1.9) | 5 (2.3) | 5 (1.6) | | | T2b | 4 (0.8) | 4 (1.8) | 0 (0.0) | | | T3 | 5 (0.9) | 2 (0.9) | 3 (1.0) | | | T3a | 120 (22.6) | 71 (32.3) | 49 (15.8) | | | T3b | 52 (9.8) | 27 (12.3) | 25 (8.1) | | | T3c | 2 (0.4) | 2 (0.9) | 0 (0.0) | | | T4 | 11 (2.1) | 9 (4.1) | 2 (0.6) | | | M (%) | | | | <0.001 | | M0 | 420 (79.2) | 152 (69.1) | 268 (86.5) | | | M1 | 78 (14.7) | 52 (23.6) | 26 (8.4) | | | MX | 30 (5.7) | 16 (7.3) | 14 (4.5) | | | Unknown | 2 (0.4) | 0 (0.0) | 2 (0.6) | | | N (%) | | | | 0.004 | | N0 | 239 (45.1) | 107 (48.6) | 132 (42.6) | | | N1 | 16 (3.0) | 12 (5.5) | 4 (1.3) | | | NX | 275 (51.9) | 101 (45.9) | 174 (56.1) | | | riskScore (median (IQR)) | 1.03 (0.48, 2.01) | 2.33 (1.66, 3.56) | 0.54 (0.37, 0.87) | <0.001 |
|
|
